Oct 14, 2020 | Laboratory Instruments & Laboratory Equipment, Laboratory News, Laboratory Pathology, Precision Medicine
Pathologists and clinical laboratory scientists know that influenza vaccines typically produce short-lived protection and researchers have new clues as to why this is true With so much interest in development of a COVID-19 vaccine, findings by researchers at Atlanta’s Emory Vaccine Center into why the vaccine for influenza (Flu) is so short-lived offer a new window on how the body’s immune system responds to invading viruses and what happens to the immunity over time. Because the autumn...